AntibioticDB

WCK2349, Alalevonadifloxacin

Fluoroquinolone

Wockhardt, India

2001

Highest development stage: Phase 3
Development active
Gram-positive activity
Combination therapy
Mechanism of Action/Target pathogen: Hospital-acquired bacterial pneumonia
GtoPDB link: https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10756
Source: http://www.wockhardt.com/pdfs/Press-Release-16-01-2020.pdf
Compound/Drug Structure: https://pubchem.ncbi.nlm.nih.gov/compound/16734914